Skip to main content
. Author manuscript; available in PMC: 2014 Jul 14.
Published in final edited form as: Tumour Biol. 2014 Jan 8;35(3):2661–2667. doi: 10.1007/s13277-013-1350-6

Fig. 4.

Fig. 4

Expression of p90/CIP2A in breast cancer and adjacent normal breast tissues by immunohistochemistry. The monoclonal anti-p90/CIP2A antibody was used as primary antibody to detect the expression of p90/CIP2A in breast cancer and adjacent normal breast tissues. a Breast cancer tissue (grade I); b breast cancer tissue (grade II); c breast cancer tissue (grade III); d an adjacent normal breast tissue had negative staining (magnification, ×400). The arrows indicate p90/CIP2A positive staining